Brief: Selecta Biosciences Reports Q2 Basic Net Income Of $0.06/Share

Cartesian Therapeutics

04/08/2022 12:58

Aug 4 (Reuters) - Selecta Biosciences Inc  SELB.O :
    * SELECTA BIOSCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * SELECTA BIOSCIENCES - BELIEVES AVAILABLE CASH, RESTRICTED
CASH,
MARKETABLE SECURITIES WILL BE SUFFICIENT TO MEET OPERATING
REQUIREMENTS INTO MID-2024
    * QTRLY BASIC NET INCOME PER SHARE OF $0.06
    * Q2 EARNINGS PER SHARE VIEW $-0.08 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5wT07 
Further company coverage:  SELB.O 

 ((Reuters.Briefs@thomsonreuters.com;))